Journal
CANCER CELL
Volume 39, Issue 3, Pages 288-293Publisher
CELL PRESS
DOI: 10.1016/j.ccell.2021.01.004
Keywords
-
Categories
Funding
- F. Hoffmann-La Roche Ltd.
- ETH Zurich
- University of Zurich
- University Hospital Zurich
- University Hospital Basel
- Biobank team from the Department of Dermatology
- Biobank and Tumor Genomic Profiling team of the Department of Pathology and Molecular Pathology at The University Hospital Zurich
- Biobank and Ovarian Cancer Research at the Department of Biomedicine, University of Basel
- Clinical Trials Center (CTC) Zurich
- Clinical Trials Unit (CTU) Basel
Ask authors/readers for more resources
The Tumor Profiler Study combines a prospective diagnostic approach with an exploratory strategy to assess the relevance of in-depth tumor profiling in supporting clinical decision-making and improving the biological understanding of the disease.
The application and integration of molecular profiling technologies create novel opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an observational trial combining a prospective diagnostic approach to assess the relevance of in-depth tumor profiling to support clinical decision-making with an exploratory approach to improve the biological understanding of the disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
